⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methane SCHEMBL27938574 | 0.97 | ADRB1 (0.41) | — | |
| Hydrochloric Acid SCHEMBL9067551 | 0.97 | ADRB1 (0.41) | — | |
| SCHEMBL1405613 | 0.83 | — | — | |
| Methane SCHEMBL28356450 | 0.81 | — | — | |
| SCHEMBL251934 | 0.81 | MEN1 (0.33) | — | |
| SCHEMBL13938850 | 0.81 | — | — | |
| SCHEMBL4366628 | 0.75 | — | — | |
| SCHEMBL3795933 | 0.75 | — | — | |
| SCHEMBL5903610 | 0.75 | — | — | |
| SCHEMBL2347952 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108484523-A | Benzo oxa- oxadiazole derivatives and its preparation method and application | 江苏省农用激素工程技术研究中心有限公司 | 2018-09-04 | — | — | CN | claimed |
| CN-104684588-B | Liquid activation agents with surfactant | 宝洁公司 | 2018-02-16 | — | — | CN | claimed |
| US-12202826-B2 | N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway | REDX PHARMA PLC (GB) | 2025-01-21 | — | — | US | disclosed |
| US-11958809-B2 | Salt of omecamtiv mecarbil and process for preparing salt | CYTOKINETICS, INC. (US) | 2024-04-16 | — | — | US | disclosed |
| US-20240101517-A1 | SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT | AMGEN INC. | 2024-03-28 | — | — | US | disclosed |
| EP-4305018-A2 | SYNTHESIS OF OMECAMTIV MECARBIL | Amgen Inc. (US) | 2024-01-17 | — | — | EP | disclosed |
| CN-117157274-A | Synthesis of olmesartan Mo Kabi mol | 安进股份有限公司 | 2023-12-01 | — | — | CN | disclosed |
| US-20230365549-A1 | N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALING PATHWAY | REDX PHARMA PLC (GB) | 2023-11-16 | — | — | US | disclosed |
| US-11814348-B2 | Oxidizing liquid media for chemical transformations | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-11-14 | — | — | US | disclosed |
| US-11702380-B2 | Synthesis of omecamtiv mecarbil | AMGEN INC. (US) | 2023-07-18 | — | — | US | disclosed |
| US-11643408-B2 | N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway | REDX PHARMA PLC (GB) | 2023-05-09 | — | — | US | disclosed |
| WO-2009012455-A1 | PROPPANTS WITH CARBIDE AND/OR NITRIDE PHASES | OXANE MATERIALS, INC. (US) | 2009-01-22 | — | — | WO | disclosed |
| WO-2008018966-A2 | A COMPOSITION AND METHOD FOR MAKING A PROPPANT | OXANE MATERIALS, INC. (US) | 2008-02-14 | — | — | WO | disclosed |
| EP-1851210-A2 | NITRO-SUBSTITUTED PHENYL-PIPERAZINE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2007-11-07 | — | — | EP | disclosed |
| EP-1676842-A1 | Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2006-07-05 | — | — | EP | disclosed |
| WO-2004078717-A1 | ACYLATED PIPERAZINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS | MERCK & CO., INC. (US) | 2004-09-16 | — | — | WO | disclosed |
| US-5561140-A | IMMUNOSUPPRESSANTS; SIDE EFFECT REDUCTION | ABBOTT LABORATORIES (US) | 1996-10-01 | — | — | US | disclosed |
| US-5530119-A | IMMUNOSUPPRESSANTS | ABBOTT LABORATORIES (US) | 1996-06-25 | — | — | US | disclosed |
| EP-0690713-A1 | SUBSTITUTED ALICYCLIC AMINE-CONTAINING MACROCYCLIC IMMUNOMODULATORS | ABBOTT LABORATORIES (US) | 1996-01-10 | — | — | EP | disclosed |
| WO-1994021254-A1 | SUBSTITUTED ALICYCLIC AMINE-CONTAINING MACROCYCLIC IMMUNOMODULATORS | ABBOTT LABORATORIES (US) | 1994-09-29 | — | — | WO | disclosed |